Strategies to Address Current Challenges in Real-World Evidence Generation in Japan.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 167, doi. 10.1007/s40801-023-00371-5
- By:
- Publication type:
- Article
Works matching IS 21989788 AND DT 2023 AND VI 10 AND IP 2
Results: 18
1
2
The Association of Pre-operative Serum Albumin Levels and Post-operative In-Hospital Death in Patients Undergoing Gastrointestinal Surgeries in Thailand: A Retrospective Cohort Study.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 341, doi. 10.1007/s40801-023-00364-4
- By:
- Publication type:
- Article
3
Perioperative Analgesics and Anesthesia as Risk Factors for Postoperative Chronic Opioid Use in Patients Undergoing Total Knee Arthroplasty: A Retrospective Cohort Study Using Japanese Hospital Claims Data.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 331, doi. 10.1007/s40801-023-00363-5
- By:
- Publication type:
- Article
4
Analysis of Adverse Events of Cholinesterase Inhibitors and NMDA Receptor Antagonists on Arrhythmias Using the Japanese Adverse Drug Event Report Database.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 321, doi. 10.1007/s40801-023-00362-6
- By:
- Publication type:
- Article
5
Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 263, doi. 10.1007/s40801-023-00355-5
- By:
- Publication type:
- Article
6
Digoxin and Standard-of-Care Therapy for Heart Failure Patients with COVID-19: Analysis of Data from the US Military Health System (MHS) Data Repository.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 299, doi. 10.1007/s40801-023-00360-8
- By:
- Publication type:
- Article
7
Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 291, doi. 10.1007/s40801-023-00359-1
- By:
- Publication type:
- Article
8
Drug Burden Index in Older Adults with Psychiatric Illnesses: A Cross-Sectional Study.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 283, doi. 10.1007/s40801-023-00357-3
- By:
- Publication type:
- Article
9
Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 271, doi. 10.1007/s40801-023-00356-4
- By:
- Publication type:
- Article
10
Patients' Perceived Importance of Medication and Adherence in Polypharmacy, a Quantitative, Cross-Sectional Study Using a Questionnaire Administered in Three Doctors' Private Practices in France.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 309, doi. 10.1007/s40801-023-00361-7
- By:
- Publication type:
- Article
11
A Retrospective Real-World Observational Study Assessing the Evolution of Bisacodyl Prescriptions in Patients with Constipation During Long-Term Treatment.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 249, doi. 10.1007/s40801-023-00354-6
- By:
- Publication type:
- Article
12
An Attempt to Replicate Randomized Trials of Diabetes Treatments Using a Japanese Administrative Claims and Health Checkup Database: A Feasibility Study.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 235, doi. 10.1007/s40801-023-00353-7
- By:
- Publication type:
- Article
13
Evidence of Accidental Dosing Errors with Immediate-Release Sodium Oxybate: Data from the US Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 225, doi. 10.1007/s40801-023-00351-9
- By:
- Publication type:
- Article
14
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 215, doi. 10.1007/s40801-022-00350-2
- By:
- Publication type:
- Article
15
Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 195, doi. 10.1007/s40801-022-00348-w
- By:
- Publication type:
- Article
16
Validation of Algorithms to Identify Bone Metastases Using Administrative Claims Data in a Japanese Hospital.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 187, doi. 10.1007/s40801-022-00347-x
- By:
- Publication type:
- Article
17
Retrospective Observational Study of Outcomes in HER2-Positive Metastatic Breast Cancer (mBC) Patients Treated with Ado-Trastuzumab Emtansine (T-DM1) and Subsequent Treatments After T-DM1 in the United States.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 177, doi. 10.1007/s40801-022-00340-4
- By:
- Publication type:
- Article
18
Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 207, doi. 10.1007/s40801-022-00349-9
- By:
- Publication type:
- Article